Granules India (GRANULES) Stock Overview

Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates, and finished dosages (FDs) in India, North America, Europe, Latin America, Africa, the Middle East, and internationally. The company's APIs in various therapeutic categories include anti-retrovirals, anti-hypertensives, anti-histamines, anti-infectives, analgesics, anti-coagulants, anti-fibriotics, and platelet inhibitors. It also offers various FDs, such as tablets, caplets, and press-fit capsules in bulk, blister packs, and bottles; and other products for oncology. The Company also exports its products. Granules India Limited was founded in 1984 and is based in Hyderabad, India.

GRANULES Stock Information

Symbol

GRANULES

Address

My Home HubHyderabad, 500081India

Founded

Trading hours

Website

https://www.granulesindia.com

Country

🇮🇳 India

Phone Number

91 40 6904 3500

Granules India (GRANULES) Price Chart

Granules India Overview: Key Details and Summary

Stock data	2023	Change
Price	$8.16	N/A
Market Cap	$2.00B	N/A
Shares Outstanding	245.41M	-0.98%
Employees	3.65K	N/A
Shareholder Equity	28.35B	9.58%

Valuation	2023	Change
P/E Ratio	0.39	N/A
P/S Ratio	3.74	N/A
P/B Ratio	0.07	N/A

Growth	2023	Change
Return on Equity	0.0022	N/A

Earnings	2023	Change
Revenue	$535.62M	N/A
Earnings	$61.54M	N/A
EPS	21.00	N/A
Earnings Yield	2.57	N/A
Gross Margin	0.4699	N/A
Operating Margin	0.1641	N/A
Net income margin	0.1149	N/A

Financial Strength	2023	Change
Total Assets	$584.25M	N/A
Total Debt	$135.35M	N/A
Cash on Hand	$37.64M	N/A
Debt to Equity	0.0087	-1.93%
Cash to Debt	0.2781	-22.34%
Current Ratio	$1.42	-6.98%